Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel

Abstract excerpt

// Ferga C. Gleeson 1 , Jesse S. Voss 2 , Benjamin R. Kipp 2 , Sarah E. Kerr 2 , John S. Van Arnam 2 , John R. Mills 2 , Cherisse A. Marcou 2 , Amber R. Schneider 2 , Zheng Jin Tu 3 , Michael R. Henry 2 and Michael J. Levy 1 1 Division of Gastroenterology & Hepatology, Mayo Clinic Rochester, MN, USA 2 Department of Laboratory Medicine-Pathology, Mayo Clinic Rochester, MN, USA 3 Divisions of Biomedical Statics &...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Neuroendocrine Tumor Research Advances
• Share to Pancreatic and Hepatic Oncology Research
• Share to Thyroid Cancer Diagnosis and Treatment